Kenya Contraceptive Devices Market Report 2022 to 2030

Kenya Contraceptive Devices Market Analysis

$ 3999

Kenya's Contraceptive Devices Market is expected to witness growth from $9 Mn in 2022 to $18 Mn in 2030 with a CAGR of 9.10% for the forecasted year 2022-30. Kenya's growing demographics, urbanization, and shifting lifestyles are all contributing to an increase in the demand for family planning services. As a result, there has been an increase in the usage of contraceptive methods for family planning. The market is segmented by type and by gender. Some key players in this market include Surgipharm Kenya, Omsai Distributors, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

ID: IN10KEMD005 CATEGORY: Medical Devices GEOGRAPHY: Kenya AUTHOR: Jigyasu Bhandari

Buy Now

Kenya Contraceptive Devices Healthcare Market Executive Analysis

Kenya's Contraceptive Devices Market is expected to witness growth from $9 Mn in 2022 to $18 Mn in 2030 with a CAGR of 9.10% for the forecasted year 2022-30. From $3258 million in 2018 to $3569 million in 2022, Kenya's total health expenditures grew. In 2023, Kenya spent 6.54% of its GDP on health, down from 6.89% in 2016. In 2020, out-of-pocket costs accounted for 23.25 per cent of Kenya's overall current health expenditures. As a percentage of Kenya's current health expenditures, out-of-pocket costs gradually declined from 36.25% in 2015 to 23.25% in 2020.

Kenya's maternal mortality rate in 2022 was 342 deaths for every 100,000 live births. This means that in Kenya, 342 women are thought to die from pregnancy-related causes for every 100,000 live births. In Kenya, the prevalence of HIV/AIDS among adults aged 15 to 49 was 4.9% in 2021, translating to over 1.5 million HIV-positive individuals. Women are more likely to have it than men (6.6% vs. 3.0%). In Kenya, when used appropriately and consistently, contraceptive methods are quite successful at preventing unplanned pregnancies. According to each woman's and couple's unique demands and preferences, they offer a broad variety of solutions. By enabling women and couples to schedule and spread out their pregnancies, contraceptive methods provide them with more control over their reproductive health. This may result in better maternal and foetal health outcomes. By enabling women and families to pursue educational and job opportunities and by lessening the financial burden of unintended births, access to contraceptive devices can improve economic outcomes for women and families.

Kenya Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

Kenya's growing demographics, urbanisation, and shifting lifestyles are all contributing to an increase in the demand for family planning services. As a result, there has been an increase in the usage of contraceptive methods for family planning. The distribution of free or heavily discounted contraceptives is one of many steps the Kenyan government has put into place to increase access to family planning services. As a result, there is now a higher need for contraceptive methods, which has increased market expansion. The alternatives available to women and couples in Kenya have increased thanks to the emergence of new and cutting-edge contraceptive methods. Because more people can now discover a contraceptive method that works for them, the market has grown.

Market Restraints

In Kenya, there are many various kinds of contraceptive methods available, some of which might be rather pricey. This may limit their access to some customers, which may put manufacturers in the market at a disadvantage. Even though family planning and contraceptive methods are receiving more attention in Kenya, there are still many people who are unaware of their advantages. This may reduce the market's need for contraceptive devices and put producers at a disadvantage. The logistics and infrastructure of Kenya make it difficult to provide contraceptive devices there. This might significantly impede market expansion and restrict firms' ability to reach consumers.

Competitive Landscape

Key Players

Surgipharm Kenya (KE)
Omsai Distributors (KE)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

In Kenya, to make sure that contraceptive devices adhere to quality and safety standards, the National Quality Control Laboratory is in charge of testing and evaluating them. In the National Reproductive Health Policy, the government declares its commitment to enhancing reproductive health and lowering maternal mortality. The policy emphasises family planning services and broadens access to contraceptives. Healthcare professionals can get information from the National Guidelines for Family Planning Services on how to deliver family planning services, including the use of contraceptive methods. Kenyan medicinal product production, importation, and distribution are all governed by the Pharmacy and Poisons Board. They control the effectiveness, safety, and calibre of contraceptive methods. A government programme called the Public-Private Partnership for Health strives to increase access to healthcare services, including family planning options. In order to improve access to healthcare services, including contraceptive devices, the programme entails collaborating with manufacturers and private healthcare providers.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.